8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements

IDEXX furnished a press release titled “IDEXX Laboratories Announces Fourth Quarter and Full Year 2025…

Filed with the SEC on February 2, 2026 · Summarized by InvestorsBot

IDEXX furnished a press release titled “IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results” (Exhibit 99.1) dated Feb 2, 2026 — furnished, not filed. $IDXX 🐾 #earnings #SECfilings

The 8‑K includes Exhibit 104 (Inline XBRL cover page). Material relating to Item 2.02 is expressly furnished, not filed. $IDXX 📄 #XBRL #regulatory

8‑K signed Feb 2, 2026 by Andrew Emerson, Executive VP, Chief Financial Officer & Treasurer of IDEXX. $IDXX ✍️ #corporategovernance #SECfilings

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from IDEXX LABORATORIES INC /DE

IDEXX ($IDXX) filed an 8‑K (Item 9.01) disclosing a Separation Agreement (Exhibit 10.1) between Nimrata…

8-K · March 26, 2026

IDEXX ($IDXX) and Nimrata Hunt, EVP Global Strategy & Commercial, agreed she’ll cease her role Apr 13,…

8-K · March 26, 2026

IDEXX ($IDXX): Director M.

8-K · February 13, 2026

IDEXX ($IDXX) announced financial results for the quarter and year ended Dec 31, 2025 on Feb 2, 2026.

8-K · February 2, 2026

IDEXX filed Item 9.01 exhibits: a Letter Agreement and an Amended & Restated Change‑in‑Control Agreement…

8-K · January 13, 2026

IDEXX LABORATORIES filed a Form 8‑K (Item 7.01) on Jan 13, 2026 furnishing a press release as Exhibit 99.1…

8-K · January 13, 2026